UB Paderborn / Katalog / Suche / in CDI

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale

Thrombosis and haemostasis, 2017, Vol.117 (12), p.2415

2017

Volltextzugriff (PDF)

Coagulation factor XIIa-kinin-mediated contribution to hypertension of chronic kidney disease

Journal of hypertension, 2014-07, Vol.32 (7), p.1523-1533

2014

Volltextzugriff (PDF)

The utility of screening for asymptomatic lower extremity deep venous thrombosis during inflammatory bowel disease flares: a pilot study

Inflammatory bowel diseases, 2013-04, Vol.19 (5), p.1053-1058

2013

Volltextzugriff (PDF)

Prophylaxis of venous thromboembolism in IBD

The Lancet (British edition), 2010-02, Vol.375 (9715), p.616-617

2010

Volltextzugriff (PDF)

Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats

Clinical science (1979), 2012-06, Vol.122 (12), p.581

2012

Volltextzugriff (PDF)

Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism

Thrombosis and haemostasis, 2002-08, Vol.88 (2), p.205

2002

Volltextzugriff (PDF)

A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa)

Journal of immunological methods, 2012-02, Vol.376 (1-2), p.132-138

2012

Volltextzugriff (PDF)

Mental-stress-induced platelet activation among patients with coronary artery disease

Psychosomatic medicine, 2009-05, Vol.71 (4), p.438-445

2009

Volltextzugriff (PDF)

A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3

Blood, 2022-11, Vol.140 (Supplement 1), p.1245-1246

2022

Volltextzugriff (PDF)

The role of recombinant factor VIIa in on-pump cardiac surgery : Proceedings of the Canadian Consensus Conference

Canadian journal of anesthesia, 2007-07, Vol.54 (7), p.573-582

2007

Volltextzugriff (PDF)

Peak plasma rivaroxaban levels in patients weighing 120 kg or greater

Thrombosis research, 2021-05, Vol.201, p.15-17

2021

Volltextzugriff (PDF)

Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms

Blood, 2017-12, Vol.130, p.1112-1112

2017

Volltextzugriff (PDF)

Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women

Trials, 2001-01, Vol.2 (3), Article 141

2001

Volltextzugriff (PDF)

Use of statins and the subsequent development of deep vein thrombosis

Archives of internal medicine (1960), 2001-06, Vol.161 (11), p.1405

2001

Volltextzugriff (PDF)

P44 Anticoagulation control in adults with congenital heart disease

Heart (British Cardiac Society), 2016-03, Vol.102 (Suppl 1), p.A22-A23

2016

Volltextzugriff (PDF)

Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial

Thrombosis and haemostasis, 2014-12, Vol.112 (6), p.1137

2014

Volltextzugriff (PDF)

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Blood, 2016-12, Vol.128 (22), p.90-90

2016

Volltextzugriff (PDF)

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Blood, 2017-12, Vol.130 (Suppl_1), p.LBA-6-LBA-6

2017

Volltextzugriff (PDF)

Inter-observer reliability of the HERDOO2 clinical decision rule

Thrombosis research, 2016-05, Vol.141, p.136-138

2016

Volltextzugriff (PDF)

CD109 is expressed on a subpopulation of CD34 + cells enriched in hematopoietic stem and progenitor cells

Experimental hematology, 1999-08, Vol.27 (8), p.1282-1294

1999

Volltextzugriff (PDF)

Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial

BLOOD, 2014-12, Vol.124 (21), p.2872-2872

2014

Volltextzugriff (PDF)

Intravenous cocaine induces platelet activation in the conscious dog

Circulation (New York, N.Y.), 1995-03, Vol.91 (5), p.1336-1340

1995

Volltextzugriff (PDF)

Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins

Blood, 2002-03, Vol.99 (5), p.1683-1691

2002

Volltextzugriff (PDF)

The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa

Thrombosis and haemostasis, 1999-12, Vol.82 (6), p.1680

1999

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale

Coagulation factor XIIa-kinin-mediated contribution to hypertension of chronic kidney disease

The utility of screening for asymptomatic lower extremity deep venous thrombosis during inflammatory bowel disease flares: a pilot study

Prophylaxis of venous thromboembolism in IBD

Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats

Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism

A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa)

Mental-stress-induced platelet activation among patients with coronary artery disease

A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3

The role of recombinant factor VIIa in on-pump cardiac surgery : Proceedings of the Canadian Consensus Conference

Peak plasma rivaroxaban levels in patients weighing 120 kg or greater

Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms

Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women

Use of statins and the subsequent development of deep vein thrombosis

P44 Anticoagulation control in adults with congenital heart disease

Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Inter-observer reliability of the HERDOO2 clinical decision rule

CD109 is expressed on a subpopulation of CD34 + cells enriched in hematopoietic stem and progenitor cells

Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial

Intravenous cocaine induces platelet activation in the conscious dog

Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins

The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa

Suchergebnisse filtern